VERAXA Biotech GmbH
 | |
| Industry sector: | Biotechnology |
| Products, services: | ADC Development and Antibody Screening |
| Locations: | 69124 Heidelberg, Carl-Friedrich-Gauß-Ring 5 |
| Date of foundation: | 2021 |
| Number of employees: | 32 |
| The company: | VERAXA is an early-stage biotechnology company with game changing functional antibody discovery and conjugation technology yielding ADCs at scale for the treatment of Cancer. Its proprietary high throughput droplet-based microfluidic platform can screen entire immune repertoires with millions of antibody secreting cells for antibody binding, functionality, and internalization on a single-cell level. VERAXA’s unique conjugation technology utilizes fastest bioorthogonal click chemistry coupled with genetic code expansion to precisely and efficiently conjugate payloads/oligos/ radionuclide at freely selectable antibody sites. |
| Area of expertise: | Biosciences, Chemistry, Mathematics, Biochemistry, Physics, Computer Sciences, Biotechnology |
| Desired qualifications: | PostDoc, PhD, master, bachelor, technicians |
| Career opportunities: | direct entry |
| Trainee program (positions/year): | No |
| Contact: | veraxa.com/jobs/ jobs@veraxa.com |
